<DOC>
	<DOCNO>NCT02108158</DOCNO>
	<brief_summary>A randomized , evaluator-blinded , comparative , study evaluate efficacy safety different injection volume botulinum toxin type A , Azzalure , glabellar line .</brief_summary>
	<brief_title>A Safety Efficacy Study Different Injections Volumes Botulinum Toxin Type A , Azzalure , Glabellar Lines</brief_title>
	<detailed_description>Clarification regard injection volume different study group : Subjects randomize Group A Group B ( 1:1 ) . - Group A : 0,63ml NaCl use reconstitute toxin vial . 0,05mL injected ( equal dose 10s.U . ) - Group B : 1,25ml NaCl use reconstitute toxin vial . 0,1 mL inject ( equal dose 10s.U. ) . The two different reconstitution volume ( contain dose 10s.U . botulinum toxin A ) compare described objective .</detailed_description>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Key Women , 18 64 year age Subjects seek treatment moderate severe glabellar line severity line important psychological impact subject , determine investigator . Key Subjects previously treat botulinum toxin product . Pregnant breast feed woman woman intend get pregnant next 12 month . Subjects sign symptom eyelid brow ptosis sign compensatory frontalis muscle activity , judge investigator . Subjects clinical subclinical neuromuscular junctional disorder ( e.g . myasthenia gravis , Lambert Eaton syndrome amyotrophic lateral sclerosis ) history dysphagia aspiration . Subjects previous current diagnosis Bell 's paresis . Subjects know bleed disorder subject take thrombolytics anticoagulant . Subjects take anticholinergic aminoglycoside antibiotic . Any prior surgery facial area , opinion investigator , may interfere result . Subjects treat filler , HA filler permanent filler , upper face one year less screening .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>